secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2025-03-06T23:59:59+00:00
Accession:  0000950170-25-034181
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organovo issues ~3M shares via warrant exercises and ATM sales, raising ~$2.3M
------------------------------------------------------------------------------

- Issued 2,967,144 shares of common stock from warrant exercises and at-the-market sales.
- Gross proceeds expected to be approximately $2.3 million, before fees and commissions.
- After issuance, total outstanding shares are 20,421,617.
- Warrant shares registered under an effective shelf registration statement (May 8, 2024).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000095017025034181/0000950170-25-034181-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000095017025034181/onvo-20250306.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-034181

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer